Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2019 | 06-2019 | 03-2019 | 12-2018 | 09-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 196,592 | 74,587 | 81,673 | 89,258 | 566,722 |
| Marketable Securities | 432,040 | 586,174 | 483,726 | 532,144 | 86,009 |
| Receivables | 19,225 | 6,453 | 6,023 | 63,684 | 23,187 |
| Inventories | 4,908 | 1,981 | N/A | N/A | N/A |
| TOTAL | $786,480 | $805,791 | $579,000 | $690,015 | $678,783 |
| Non-Current Assets | |||||
| PPE Net | 43,208 | 44,865 | 45,828 | 127,198 | 127,908 |
| Investments And Advances | 10,999 | 10,915 | 132,203 | 55,820 | 40,602 |
| Other Non-Current Assets | 53,277 | 53,495 | 55,366 | 7,565 | 8,348 |
| TOTAL | $107,484 | $109,275 | $233,397 | $190,583 | $176,858 |
| Total Assets | $893,964 | $915,066 | $812,397 | $880,598 | $855,641 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,055 | 4,060 | 3,772 | 9,139 | 10,131 |
| Accrued Expenses | 70,825 | 66,545 | 66,278 | 66,123 | 52,598 |
| TOTAL | $87,286 | $82,812 | $93,920 | $89,033 | $100,426 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 257 | 136 | 12,104 | 13,771 | 37,697 |
| Other Non-Current Liabilities | 53,539 | 37,246 | 27,969 | 123,948 | 27,239 |
| TOTAL | $192,960 | $183,952 | $209,983 | $263,095 | $264,633 |
| Total Liabilities | $280,246 | $266,764 | $303,903 | $352,128 | $365,059 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 3,490 | 3,477 | 3,449 | 3,422 | 3,399 |
| Common Shares | 872 | 868 | 861 | 854 | 848 |
| Retained earnings | -686,597 | -637,158 | -753,161 | -715,827 | -736,780 |
| Other shareholders' equity | 19,047 | 18,809 | 18,334 | 16,990 | 16,701 |
| TOTAL | $613,718 | $648,302 | $508,494 | $528,470 | $490,582 |
| Total Liabilities And Equity | $893,964 | $915,066 | $812,397 | $880,598 | $855,641 |